33 Publications (Page 1 of 2)
2021
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trialFisher, Michael J⋅Fisher, Michael J⋅Fisher, Michael J⋅Fisher, Michael J⋅Fisher, Michael J⋅Fisher, Michael J⋅Rhodes, Steven D⋅Rhodes, Steven D⋅Rhodes, Steven D⋅Rhodes, Steven D⋅Rhodes, Steven D⋅Rhodes, Steven D⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Wolters, Pamela L⋅Wolters, Pamela L⋅Wolters, Pamela L⋅Wolters, Pamela L⋅Wolters, Pamela L⋅Wolters, Pamela L⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Zhang, Chi⋅Angus, Steven P⋅Angus, Steven P⋅Angus, Steven P⋅Angus, Steven P⋅Angus, Steven P⋅Angus, Steven P⋅Johnson, Gary L⋅Johnson, Gary L⋅Johnson, Gary L⋅Johnson, Gary L⋅Johnson, Gary L⋅Johnson, Gary L⋅Packer, Roger J⋅Packer, Roger J⋅Packer, Roger J⋅Packer, Roger J⋅Packer, Roger J⋅Packer, Roger J⋅Allen, Jeffrey C⋅Allen, Jeffrey C⋅Allen, Jeffrey C⋅Allen, Jeffrey C⋅Allen, Jeffrey C⋅Allen, Jeffrey C⋅Ullrich, Nicole J⋅Ullrich, Nicole J⋅Ullrich, Nicole J⋅Ullrich, Nicole J⋅Ullrich, Nicole J⋅Ullrich, Nicole J⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Gutmann, David H⋅Gutmann, David H⋅Gutmann, David H⋅Gutmann, David H⋅Gutmann, David H⋅Gutmann, David H⋅Plotkin, Scott R⋅Plotkin, Scott R⋅Plotkin, Scott R⋅Plotkin, Scott R⋅Plotkin, Scott R⋅Plotkin, Scott R⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Widemann, Brigitte C⋅Smith, Abbi E⋅Smith, Abbi E⋅Smith, Abbi E⋅Smith, Abbi E⋅Smith, Abbi E⋅Smith, Abbi E⋅Bessler, Waylan K⋅Bessler, Waylan K⋅Bessler, Waylan K⋅Bessler, Waylan K⋅Bessler, Waylan K⋅Bessler, Waylan K⋅Su-Jung, Park⋅Su-Jung, Park⋅Su-Jung, Park⋅Su-Jung, Park⋅Su-Jung, Park⋅Su-Jung, Park⋅Mund, Julie A⋅Mund, Julie A⋅Mund, Julie A⋅Mund, Julie A⋅Mund, Julie A⋅Mund, Julie A⋅Jiang, Li⋅Jiang, Li⋅Jiang, Li⋅Jiang, Li⋅Jiang, Li⋅Jiang, Li⋅Robinson, Coretta T⋅Robinson, Coretta T⋅Robinson, Coretta T⋅Robinson, Coretta T⋅Robinson, Coretta T⋅Robinson, Coretta T⋅Cutter, Gary R⋅Cutter, Gary R⋅Cutter, Gary R⋅Cutter, Gary R⋅Cutter, Gary R⋅Cutter, Gary R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Korf, Bruce R⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Armstrong, Amy E⋅Blakeley, Jaishri O⋅Blakeley, Jaishri O⋅Blakeley, Jaishri O⋅Blakeley, Jaishri O⋅Blakeley, Jaishri O⋅Blakeley, Jaishri O⋅Wade, Clapp D⋅Wade, Clapp D⋅Wade, Clapp D⋅Wade, Clapp D⋅Wade, Clapp D and Wade, Clapp DNature Medicine, vol. 27, (no. 1), pp. 165-173, Jan 2021.
| Journal Article
2020
Azacitidine As a Post-Stem Cell Transplant Maintenance for Children with Acute Myeloid LeukemiaOnishi, Toshihiro⋅Onishi, Toshihiro⋅Skiles, Jodi L⋅Skiles, Jodi L⋅Goebel, W. Scott⋅Goebel, W. Scott⋅Robertson, Kent and Robertson, KentBiology of Blood and Marrow Transplantation, vol. 26, (no. 3), pp. S119, March 2020.
| Journal Article
Successful Allogeneic Stem Cell Transplant in Pediatric Patients With Diminished Left Ventricular Ejection FractionsLyon, Shannon M⋅Lyon, Shannon M⋅Lyon, Shannon M⋅Lyon, Shannon M⋅Schamberger, Marcus S⋅Schamberger, Marcus S⋅Schamberger, Marcus S⋅Schamberger, Marcus S⋅Delgado, David C⋅Delgado, David C⋅Delgado, David C⋅Delgado, David C⋅Skiles, Jodi L⋅Skiles, Jodi L⋅Skiles, Jodi L⋅Skiles, Jodi L⋅Goebel, William S⋅Goebel, William S⋅Goebel, William S⋅Goebel, William S⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Parent, John J⋅Parent, John J⋅Parent, John J and Parent, John JJournal of pediatric hematology/oncology, pp. 1, 2020-Apr-02.
| Journal Article
2018
NFM-01. NF105: A PHASE II PROSPECTIVE STUDY OF CABOZANTINIB (XL184) FOR PLEXIFORM NEUROFIBROMAS IN SUBJECTS WITH NEUROFIBROMATOSIS TYPE 1: A NEUROFIBROMATOSIS CLINICAL TRIAL CONSORTIUM (NFCTC) STUDYShih, Chie-Schin⋅Shih, Chie Schin⋅Shih, Chie-Schin⋅Blakely, Jaishri⋅Blakely, Jaishri⋅Blakely, Jaishri⋅Clapp, Wade⋅Clapp, Wade⋅Clapp, Wade⋅Wolters, Pam⋅Wolters, Pam⋅Wolters, Pam⋅Dombi, Eva⋅Dombi, Eva⋅Dombi, Eva⋅Cutter, Gary⋅Cutter, Gary⋅Cutter, Gary⋅Ullrich, Nichole⋅Ullrich, Nichole⋅Ullrich, Nichole⋅Allen, Jeffrey⋅Allen, Jeffrey⋅Allen, Jeffrey⋅Packer, Roger⋅Packer, Roger⋅Packer, Roger⋅Goldman, Stewart⋅Goldman, Stewart⋅Goldman, Stewart⋅Gutmann, David⋅Gutmann, David⋅Gutmann, David⋅Plotkin, Scott⋅Plotkin, Scott⋅Plotkin, Scott⋅Rosser, Tena⋅Rosser, Tena⋅Rosser, Tena⋅Robertson, Kent⋅Robertson, Kent⋅Robertson, Kent⋅Widemann, Brigitte⋅Widemann, Brigitte⋅Widemann, Brigitte⋅Korf, Bruce⋅Korf, Bruce⋅Korf, Bruce⋅Fisher, Michael⋅Fisher, Michael and Fisher, MichaelNeuro-Oncology, vol. 20, (no. suppl_2), pp. i142, 20180622.
| Journal Article
2014
Biomarkers for Diagnosis and Prognosis of Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell TransplantationMumaw, Christen L⋅Mumaw, Christen L⋅Mumaw, Christen L⋅Mumaw, Christen L⋅Mumaw, Christen L⋅Akil, Ayman⋅Akil, Ayman⋅Akil, Ayman⋅Akil, Ayman⋅Akil, Ayman⋅Velez de Mendizabal, Nieves⋅Velez de Mendizabal, Nieves⋅Velez de Mendizabal, Nieves⋅Velez de Mendizabal, Nieves⋅Velez de Mendizabal, Nieves⋅Zhang, Qing⋅Zhang, Qing⋅Zhang, Qing⋅Zhang, Qing⋅Zhang, Qing⋅Raiker, Nisha⋅Raiker, Nisha⋅Raiker, Nisha⋅Raiker, Nisha⋅Raiker, Nisha⋅Yu, Jeffrey⋅Yu, Jeffrey⋅Yu, Jeffrey⋅Yu, Jeffrey⋅Yu, Jeffrey⋅Diaz-Ricart, Maribel⋅Diaz-Ricart, Maribel⋅Diaz-Ricart, Maribel⋅Diaz-Ricart, Maribel⋅Diaz-Ricart, Maribel⋅Carreras, Enric⋅Carreras, Enric⋅Carreras, Enric⋅Carreras, Enric⋅Carreras, Enric⋅Haneline, Laura S⋅Haneline, Laura S⋅Haneline, Laura S⋅Haneline, Laura S⋅Haneline, Laura S⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Elmore, Lindsey⋅Elmore, Lindsey⋅Elmore, Lindsey⋅Elmore, Lindsey⋅Elmore, Lindsey⋅Case, Rose⋅Case, Rose⋅Case, Rose⋅Case, Rose⋅Case, Rose⋅Renbarger, Jamie⋅Renbarger, Jamie⋅Renbarger, Jamie⋅Renbarger, Jamie⋅Renbarger, Jamie⋅Hanash, Samir⋅Hanash, Samir⋅Hanash, Samir⋅Hanash, Samir⋅Hanash, Samir⋅Bies, Robert R⋅Bies, Robert R⋅Bies, Robert R⋅Bies, Robert R⋅Bies, Robert R⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie⋅Paczesny, Sophie and Paczesny, SophieBlood, vol. 124, (no. 21), pp. 663, 2014-12-06.
| Journal Article
2013
Recommendations for imaging tumor response in neurofibromatosis clinical trialsDombi, Eva⋅Dombi, Eva⋅Ardern-Holmes, Simone⋅Ardern-Holmes, Simone L⋅Babovic-Vuksanovic, Dusica⋅Babovic-Vuksanovic, Dusica⋅Barker, Fred⋅Barker, Frederick G⋅Connor, Steve⋅Connor, Steve⋅Evans, D G⋅Evans, D⋅Fisher, Michael⋅Fisher, Michael J⋅Goutagny, Stephane⋅Goutagny, Stephane⋅Harris, Gordon J⋅Harris, Gordon⋅Jaramillo, Diego⋅Jaramillo, Diego⋅Karajannis, Matthias⋅Karajannis, Matthias A⋅Korf, Bruce R⋅Korf, Bruce⋅Mautner, Victor⋅Mautner, Victor⋅Plotkin, Scott⋅Plotkin, Scott R⋅Poussaint, Tina Y⋅Poussaint, Tina⋅Robertson, Kent⋅Robertson, Kent⋅Shih, Chie-Schin⋅Shih, Chie Schin⋅Widemann, Brigitte and Widemann, Brigitte CNeurology, vol. 81, (no. 21_supplement_1 Suppl 1), pp. S40, 2013-November-19.
| Journal Article
2012
Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent A⋅Robertson, Kent⋅Robertson, Kent A⋅Nalepa, Grzegorz⋅Nalepa, Grzegorz⋅Nalepa, Grzegorz⋅Nalepa, Grzegorz⋅Nalepa, Grzegorz⋅Yang, Feng-Chun⋅Yang, Feng-Chun⋅Yang, Feng-Chun⋅Yang, Feng-Chun⋅Yang, Feng-Chun⋅Bowers, Daniel C⋅Bowers, Daniel C⋅Bowers, Daniel C⋅Bowers, Daniel C⋅Bowers, Daniel C⋅Ho, Chang Y⋅Ho, Chang Y⋅Ho, Chang Y⋅Ho, Chang Y⋅Ho, Chang Y⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Croop, James M⋅Croop, James M⋅Croop, James M⋅Croop, James M⋅Croop, James M⋅Vik, Terry A⋅Vik, Terry A⋅Vik, Terry A⋅Vik, Terry A⋅Vik, Terry A⋅Denne, Scott C⋅Denne, Scott C⋅Denne, Scott C⋅Denne, Scott C⋅Denne, Scott C⋅Parada, Luis F⋅Parada, Luis F⋅Parada, Luis F⋅Parada, Luis F⋅Parada, Luis F⋅Hingtgen, Cynthia M⋅Hingtgen, Cynthia M⋅Hingtgen, Cynthia M⋅Hingtgen, Cynthia M⋅Hingtgen, Cynthia M⋅Walsh, Laurence E⋅Walsh, Laurence E⋅Walsh, Laurence E⋅Walsh, Laurence E⋅Walsh, Laurence E⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Pradhan, Kamnesh R⋅Pradhan, Kamnesh R⋅Pradhan, Kamnesh R⋅Pradhan, Kamnesh R⋅Pradhan, Kamnesh R⋅Edwards-Brown, Mary K⋅Edwards-Brown, Mary K⋅Edwards-Brown, Mary K⋅Edwards-Brown, Mary K⋅Edwards-Brown, Mary K⋅Cohen, Mervyn D⋅Cohen, Mervyn D⋅Cohen, Mervyn D⋅Cohen, Mervyn D⋅Cohen, Mervyn D⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Fletcher, James W⋅Travers, Jeffrey B⋅Travers, Jeffrey B⋅Travers, Jeffrey B⋅Travers, Jeffrey B⋅Travers, Jeffrey B⋅Staser, Karl W⋅Staser, Karl W⋅Staser, Karl W⋅Staser, Karl W⋅Staser, Karl W⋅Lee, Melissa W⋅Lee, Melissa W⋅Lee, Melissa W⋅Lee, Melissa W⋅Lee, Melissa W⋅Sherman, Marcie R⋅Sherman, Marcie R⋅Sherman, Marcie R⋅Sherman, Marcie R⋅Sherman, Marcie R⋅Davis, Cynthia J⋅Davis, Cynthia J⋅Davis, Cynthia J⋅Davis, Cynthia J⋅Davis, Cynthia J⋅Miller, Lucy C⋅Miller, Lucy C⋅Miller, Lucy C⋅Miller, Lucy C⋅Miller, Lucy C⋅Ingram, David A⋅Ingram, David A⋅Ingram, David A⋅Ingram, David A⋅Ingram, David A⋅Clapp, D W⋅Clapp, D. Wade⋅Clapp, D. Wade⋅Clapp, D. Wade and Clapp, D. WadeThe lancet oncology, vol. 13, (no. 12), pp. 1218-24, 2012/Dec.
| Journal Article
Marrow signal changes observed in follow-up whole-body MRI studies in children and young adults with neurofibromatosis type 1 treated with imatinib mesylate (Gleevec) for plexiform neurofibromasKarmazyn, Boaz⋅Karmazyn, Boaz⋅Cohen, Mervyn⋅Cohen, Mervyn⋅Jennings, Samuel⋅Jennings, Samuel⋅Robertson, Kent and Robertson, KentPediatric Radiology, vol. 42, (no. 10), pp. 1218-22, Oct 2012.
| Journal Article
2010
Inhibition of the redox function of APE1/Ref-1 in myeloid leukemia cell lines results in a hypersensitive response to retinoic acid-induced differentiation and apoptosis.Fishel, Melissa L⋅Fishel, Melissa⋅Colvin, E.⋅Colvin, E S⋅Luo, Meihua⋅Luo, Meihua⋅Kelley, Mark⋅Kelley, Mark⋅Robertson, Kent and Robertson, Kent AExperimental hematology, vol. 38, (no. 12), pp. 1178-88, 2010/Dec.
| Journal Article
Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia.Nelson, Robert P⋅Yu, Menggang⋅Schwartz, Jennifer⋅Robertson, Michael J⋅Hromas, Robert A⋅Fausel, C A⋅Vance, Gail H⋅Dlouhy, Stephen R⋅Baute, J A⋅Cox, E A⋅Wood, L L⋅Srivastava, Shivani⋅Robertson, Kent⋅Haut, P R⋅Farag, Sherif S⋅Abonour, Rafat⋅Cornetta, Kenneth G and Cripe, Larry DBone marrow transplantation, vol. 45, (no. 8), pp. 1300-8, 2010/Aug.
| Journal Article
Safety and Efficacy of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil®) + G-CSF In Pediatric Patients with Malignant DisordersShenoy, Shalini⋅Asselin, Barbara⋅Dalal, Jignesh⋅Goyal, Rakesh⋅Kaufman, Jonathan L⋅Loeb, David⋅McCarty, John⋅Robertson, Kent⋅Strahlendorf, Caron⋅Walters, Mark C⋅Angell, Jennifer⋅Huebner, Dirk and Shaw, Peter JBlood, vol. 116, (no. 21), pp. 2245, 2010-11-19.
| Journal Article
2008
Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.Yang, Feng Chun⋅Yang, Feng-Chun⋅Yang, Feng Chun⋅Ingram, David A⋅Ingram, David A⋅Ingram, David A⋅Chen, Shi⋅Chen, Shi⋅Chen, Shi⋅Zhu, Yuan⋅Zhu, Yuan⋅Zhu, Yuan⋅Yuan, Jin⋅Yuan, Jin⋅Yuan, Jin⋅Li, Xiaohong⋅Li, Xiaohong⋅Li, Xiaohong⋅Yang, Xianlin⋅Yang, Xianlin⋅Yang, Xianlin⋅Knowles, Scott⋅Knowles, Scott⋅Knowles, Scott⋅Horn, Whitney⋅Horn, Whitney⋅Horn, Whitney⋅Li, Yan⋅Li, Yan⋅Li, Yan⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Zhang, Shaobo⋅Yang, Yanzhu⋅Yang, Yanzhu⋅Yang, Yanzhu⋅Vakili, Saeed T⋅Vakili, Saeed T⋅Vakili, Saeed T⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Burns, Dennis⋅Burns, Dennis K⋅Burns, Dennis⋅Robertson, Kent⋅Robertson, Kent⋅Robertson, Kent⋅Hutchins, Gary⋅Hutchins, Gary⋅Hutchins, Gary⋅Parada, Luis F⋅Parada, Luis F⋅Parada, Luis F⋅Clapp, D. Wade⋅Clapp, D. W and Clapp, D. WadeCell, vol. 135, (no. 3), pp. 437-48, 2008/Oct/31.
| Journal Article
Unrelated cord blood transplantation for severe congenital neutropenia: Report of two cases with very different transplant coursesMarkel, Melissa K⋅Markel, Melissa K⋅Haut, Paul R⋅Haut, Paul R⋅Renbarger, Jamie A⋅Renbarger, Jamie A⋅Robertson, Kent A⋅Robertson, Kent A⋅Scott Goebel, W and Scott Goebel, WPediatric Transplantation, vol. 12, (no. 8), pp. 901, December 2008.
| Journal Article
2007
CSK controls retinoic acid receptor (RAR) signaling: a RAR-c-SRC signaling axis is required for neuritogenic differentiation.Dey, Nandini⋅De, Pradip K⋅Wang, Mu⋅Zhang, Hongying⋅Dobrota, Erika A⋅Robertson, Kent A and Durden, Donald LMolecular and cellular biology, vol. 27, (no. 11), pp. 4179-4197, June 2007.
| Journal Article
Epstein-Barr???associated Leiomyomatosis and T-cell Chimerism After Haploidentical Bone Marrow Transplantation for Severe Combined Immunodeficiency DiseaseAtluri, Srilatha⋅Neville, Kathleen⋅Davis, Mary⋅Robertson, Kent A⋅Marshalleck, Francis E⋅O'Malley, Dennis P⋅Buckley, Rebecca H and Nelson, Jr, Robert PJournal of pediatric hematology/oncology, vol. 29, (no. 3), pp. 172, 2007-Mar.
| Journal Article
Inhibition of the Redox Function of Ape-1/ref-1 in Myeloid Leukemia Cells Results in Enhanced Sensitivity to Retinoic Acid Induced Differentiation and ApoptosisRobertson, Kent A⋅Robertson, Kent A⋅Colvin, Edwin S⋅Colvin, Edwin S⋅Kelley, Mark R and Kelley, Mark RBlood, vol. 110, (no. 11), pp. 4217, 2007-11-16.
| Journal Article
2006
Ape-1/ref-1 Mediated Redox Regulation of Retinoic Acid Receptor Transcription Function in Myeloid Leukemia Cell Differentiation and ApoptosisRobertson, Kent A⋅Robertson, Kent A⋅Colvin, Edwin S⋅Colvin, Edwin S⋅Luo, Meihua⋅Luo, Meihua⋅Reed, April⋅Reed, April⋅Kelley, Mark R and Kelley, Mark RBlood, vol. 108, (no. 11), pp. 1924, 2006-11-16.
| Journal Article
2005
Lack of EGF receptor contributes to drug sensitivity of human germline cellsPark, S-J⋅Armstrong, S.⋅Kim, C-H⋅Yu, Menggang⋅Robertson, Kent A⋅Kelley, Mark R and Lee, S-HThe British Journal of Cancer, vol. 92, (no. 2), pp. 334-41, Jan 31, 2005.
| Journal Article
Redox Regulation of Retinoic Acid Receptor Function in Myeloid Leukemia Cell Differentiation and ApoptosisRobertson, Kent A⋅Robertson, Kent A⋅Luo, Meihua⋅Luo, Meihua⋅Chastain, Ashley⋅Chastain, Ashley⋅Colvin, Scott⋅Colvin, Scott⋅Reed, April⋅Reed, April⋅Kelley, Mark R and Kelley, Mark RBlood, vol. 106, (no. 11), pp. 2483, 2005-11-16.
| Journal Article
2003
Update on late relapse of germ cell tumor: a clinical and molecular analysis.George, David W⋅Foster, Richard S⋅Hromas, Robert A⋅Robertson, Kent A⋅Vance, Gail H⋅Ulbright, Thomas M⋅Gobbett, Troy A⋅Heiber, Devan J⋅Heerema, Nyla A⋅Ramsey, Heather C⋅Thurston, Virginia C⋅Jung, Sin Ho⋅Shen, Jianzhao⋅Finch, David E⋅Kelley, Mark R and Einhorn, Lawrence HJournal of Clinical Oncology, vol. 21, (no. 1), pp. 113-22, 2003/Jan/1.
| Journal Article
2002
The embryonic stem cell transcription factors Oct-4 and FoxD3 interact to regulate endodermal-specific promoter expressionGuo, Y.⋅Costa, Robert H⋅Ramsey, H.⋅Starnes, T.⋅Vance, Gail H⋅Robertson, Kent A⋅Kelley, Mark R⋅Reinbold, R.⋅Schöler, Hans R and Hromas, Robert AProceedings of the National Academy of Sciences, USA, vol. 99, (no. 6), pp. 3663-3667, 2002.
| Journal Article
Unrelated donor bone marrow transplantation for children with juvenile myelomonocytic leukaemiaSmith, Franklin O⋅Smith, Franklin O⋅King, Roberta⋅King, Roberta⋅Nelson, Gene⋅Nelson, Gene⋅Wagner, John E⋅Wagner, John E⋅Robertson, Kent A⋅Robertson, Kent A⋅Sanders, Jean E⋅Sanders, Jean E⋅Bunin, Nancy⋅Bunin, Nancy⋅Emaunel, Peter D⋅Emaunel, Peter D⋅Davies, Stella M and Davies, Stella MBritish Journal of Haematology, vol. 116, (no. 3), pp. 724, 2002.
| Journal Article
2001
Altered Expression of Ape1/ref-1 in Germ Cell Tumors and Overexpression in NT2 Cells Confers Resistance to Bleomycin and RadiationRobertson, Kent⋅Robertson, Kent⋅Robertson, Kent⋅Robertson, Kent⋅Bullock, Heather⋅Bullock, Heather⋅Bullock, Heather⋅Bullock, Heather⋅Xu, Yi⋅Xu, Yi⋅Xu, Yi⋅Xu, Yi⋅Tritt, Renee⋅Tritt, Renee⋅Tritt, Renee⋅Tritt, Renee⋅Zimmerman, Erika⋅Zimmerman, Erika⋅Zimmerman, Erika⋅Zimmerman, Erika⋅Ulbright, Thomas⋅Ulbright, Thomas⋅Ulbright, Thomas⋅Ulbright, Thomas⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Foster, Richard⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Einhorn, Lawrence⋅Kelley, Mark⋅Kelley, Mark⋅Kelley, Mark and Kelley, MarkCancer Research, vol. 61, (no. 5), pp. 2220, 20010301.
| Journal Article
2000
Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantationThomson, Blythe G⋅Thomson, Blythe G⋅Robertson, Kent A⋅Robertson, Kent A⋅Gowan, Darla⋅Gowan, Darla⋅Heilman, Doug⋅Heilman, Doug⋅Broxmeyer, Hal E⋅Broxmeyer, Hal E⋅Emanuel, David⋅Emanuel, David⋅Kotylo, Patricia⋅Kotylo, Patricia⋅Brahmi, Zacharie⋅Brahmi, Zacharie⋅Smith, Franklin O and Smith, Franklin OBlood, vol. 96, (no. 8), pp. 2711, 2000-10-15.
| Journal Article
1998
A Positive Effect of p21cip1/waf1in the Colony Formation from Murine Myeloid Progenitor Cells as Assessed by Retroviral-Mediated Gene TransferBraun, Stephen E⋅Braun, Stephen E⋅Mantel, Charlie⋅Mantel, Charlie⋅Rosenthal, Marc⋅Rosenthal, Marc⋅Cooper, Scott⋅Cooper, Scott⋅Liu, Lisa⋅Liu, Lisa⋅Robertson, Kent A⋅Robertson, Kent A⋅Hromas, Robert⋅Hromas, Robert⋅Broxmeyer, Hal E and Broxmeyer, Hal EBlood Cells, Molecules and Diseases, vol. 24, (no. 2), pp. 148, June 1998.
| Journal Article